Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Two Chinese Drug Makers Said To Plan IPOs Elsewhere

This article was originally published in PharmAsia News

Executive Summary

A Hong Kong newspaper reports two major Chinese drug makers plan to issue initial public offerings away from mainland China, one in Hong Kong, the other in New York. The South China Morning Post said the China National Pharmaceutical Group plans to issue an initial public offering later this year in Hong Kong to raise $750 million, while CITIC Pharmaceutical considers a $200 million offering in New York next year. China National, known as Sinopharm, would spin off its subsidiaries for distribution and manufacturing, both located in mainland China, the report said. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts